Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

LX Medical Corporation
Profile last edited on: 1/7/2024      CAGE: 6FUS6      UEI: C155C9LUAK65

Business Identifier: Image guided lung intervention
Year Founded
2011
First Award
2016
Latest Award
2017
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

315 Oak Street
Westwood, MA 02090
   (781) 762-2569
   N/A
   www.lx-medical.com
Location: Single
Congr. District: 08
County: Norfolk

Public Profile

LX Medical Corporation is an early stage firm organized around addressing unmet needs in lung cancer diagnosis and treatment. Principals of the firm have been working on bringing to use condition a suite of endobronchial imaging probes and image-guided bronchoscopic tools. The effort has been that these be used by interventional pulmonologists and thoracic surgeons to improve outcomes in diagnostic and therapeutic medical procedures for several lung diseases.

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$447,686
Phase II Dollars
$50,000
Total Awarded
$497,686

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2017 1 NIH $223,403
Project Title: High-Resolution Multi-Modality Endoscopic Imaging Probes for Diagnosing Rejection in Lung Transplant Recipients
2017 1 NIH $274,283
Project Title: Biopsy Probes with Real-time Multi-modality Image Guidance for Peripheral Lung Nodules

Key People / Management

  Andrei Vertikov -- CTO

Company News

There are no news available.